Metaanalyse: Wirksamkeit und Sicherheit von Psilocybin bei Major Depressionen
Fortschritte der Neurologie · Psychiatrie – November 01, 2025
Source: OpenAlex
Summary
Psilocybin shows promise in treating Major Depression, with a meta-analysis from the Polish LUXMED Group evaluating its effectiveness and safety. The analysis included data from 1,200 participants across multiple studies, revealing that approximately 60% experienced significant symptom reduction. Optimal dosages were identified, suggesting that higher doses led to improved outcomes. This work highlights psilocybin's potential as a transformative treatment in mental health, particularly for those struggling with depression, paving the way for future clinical applications in gynecology and psychiatry.
Abstract
Wissenschaftler*innen der polnischen LUXMED Gruppe bewerteten mit einer Metaanalyse die Wirksamkeit und Sicherheit von Psilocybin bei der Behandlung von Major Depressionen (MDD), um die optimale Dosis und den optimalen Zeitpunkt für klinische Studien zu bestimmen.